Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.
作者信息
Freeman C L, Dixon M, Houghton R, Kreuzer K-A, Fingerle-Rowson G, Herling M, Humphrey K, Böttcher S, de Costa C S, Iglesias V, Stilgenbauer S, Gribben J, Hallek M, Goede V
机构信息
Department of Haemato-Oncology, John Vane Cancer Centre, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK.
Department of Biostatistics, Roche Products Limited, Welwyn Garden City, UK.
出版信息
Leukemia. 2016 Aug;30(8):1763-6. doi: 10.1038/leu.2016.41. Epub 2016 Mar 4.
Abstract
摘要
Zotero 插件